項目 |
作者 |
文章標題 |
期刊 |
1 |
Hsu JY, Chu FY, Wang PH, Wu ML |
Unusual hard metal lung disease: bronchiolocentric interstitial pneumonia. |
Occup Med (Lond). 2024 May 3:kqae030. |
2 |
Hsu JY, Chiang SO, Yang CC, Mao YC |
A Nationwide Study on the Risks of Complications and Healthcare Costs of Snakebite Envenomation in Taiwan. |
Am J Trop Med Hyg. 2024 May 7:tpmd240030. |
3 |
Hsieh CY, Hsu JY, Yang CC. |
Predictive factors for severe outcomes in substance abuse-related emergency visits: A 5-year retrospective analysis at a medical center in Taiwan. |
J Chin Med Assoc. 2024 Jan 1;87(1):40-47. |
4 |
Hsu JY, Sun HY, Chen LY, Chang SY, Chuang YC, Huang YS, Su YC, Liu WC, Hung CC. |
Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide. |
J Glob Antimicrob Resist. 2024 Mar;36:426-435. |
5 |
Hsu JY, Hung CC, Tsou TP, Chen WC. |
Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022. |
PLoS Negl Trop Dis. 2023 Oct 2;17(10):e0011421. |
6 |
Hsu JY, Chiang SO, Yang CC, Hsieh TW, Chung CJ, Mao YC. |
Nationwide and long-term epidemiological research of snakebite envenomation in Taiwan during 2002-2014 based on the use of snake antivenoms: A study utilizing National Health Insurance Database. |
PLoS Negl Trop Dis. 2023 Jun 8;17(6):e0011376. |
7 |
Hsu JY, Sun HY, Hsieh TW, Chang SY, Chuang YC, Huang YS, Hsiao CY, Su YC, Liu WC, Chang SF, Hung CC |
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy. |
J Glob Antimicrob Resist. 2022 Jun;29:7-16. |
8 |
Hsu JY, Cheng A, Ku CC, Chen YC, Wang JT, Hsieh TW, Sheng WH, Chang SC, Wu UI |
Mycobacterium abscessus and Mycobacterium massiliense exhibit distinct host and organ specificity: a cross-sectional study. |
Int J Infect Dis. 2022 Mar;116:21-26. |
9 |
Hsu JY, Liu PY, Tseng CH, Liu CW, Yang WT, Huang WH, Li SY, Liao YC, Wu MJ |
COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting. |
J Multidiscip Healthc. 2021 Oct 27;14:3027-3034. |
10 |
Hsu JY, Mao YC, Liu PY, Lai KL |
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19. |
Pharmaceuticals (Basel). 2021 Sep 23;14(10):955. |
11 |
Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019. |
J Formos Med Assoc. 2021 Nov;120(11):1994-2002. |